Sai Life Sciences Limited (BOM:544306)

Market Cap	315.91B +68.1%
Revenue (ttm)	22.50B +17.7%
Net Income	3.62B +48.2%
EPS	17.02 +43.2%
Shares Out	n/a
PE Ratio	87.35
Forward PE	70.27
Dividend	n/a
Ex-Dividend Date	n/a

Volume	11,325
Open	1,475.60
Previous Close	1,484.15
Day's Range	1,462.80 - 1,514.75
52-Week Range	786.15 - 1,697.00
Beta	n/a
Analysts	Buy
Price Target	1,579.43 (+6.23%)
Earnings Date	Nov 5, 2026

About Sai Life Sciences

Sai Life Sciences Limited operates as a contract research, development, and manufacturing organization (CRDMO) in India and internationally. It offers medicinal chemistry, pharmacokinetics, clinical and commercial manufacturing, and process development services. The company was formerly known as SAI Advantium Pharma Limited and changed its name to Sai Life Sciences Limited in July 2006. Sai Life Sciences Limited was incorporated in 1999 and is headquartered in Hyderabad, India.

• Industry: Diagnostics & Research
• Sector: Healthcare
• Founded: 1999
• Employees: 5,224
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 544306

Financial Performance

In fiscal year 2026, Sai Life Sciences's revenue was 21.92 billion, an increase of 29.38% compared to the previous year's 16.95 billion. Earnings were 3.49 billion, an increase of 105.08%.

Analyst Summary

According to 8 analysts, the average rating for 544306 stock is "Buy." The 12-month stock price target is ₹1,579, which is an increase of 6.23% from the latest price.

Price Target

₹1,579

(6.23% upside)

Analyst Consensus: Buy

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Oct 28, 2026

Data Sources Report a data error